Project Grant R34DA059770
Award Date 7/1/24
Completion Date 6/30/27
Dollars Obligated $732K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), totaling $444,826, is focused on adapting and testing an innovative, trauma-informed intervention to reduce overdose risk among women re-entering the community from prison. The key activities include: 1) Adapting the Trust-Based Relational Intervention (TBRI) approach by engaging stakeholders to align it with the unique needs of justice-involved women,...
- This Project Grant award of $189,500 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to determine the extent of cardiovascular disease (CVD) among people with opioid use disorder (OUD) and explore ways to prevent CVD in this population. The key objectives are to: 1) examine the relationship between CVD and OUD using Transformed Medicaid Statistical Information System data, and 2) assess the impact of Medicaid Health Homes...
- PEACE Platform Development and Evaluation Biomotivate LLC received $613,744 under a Project Grant from the National Institute on Drug Abuse (NIDA) Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 1, 2025, with completion targeted for July 31, 2026. The award funds development and evaluation of the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to complement existing opioid use disorder (OUD) treatment...
- The National Institute on Drug Abuse (NIDA) awarded a $2,729,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Rhode Island. The purpose of this 2-year award, with a start date of September 15, 2024, is to rigorously develop and evaluate a mobile health intervention for adults with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The proposed mobile app...
- The National Institute on Drug Abuse (NIDA) awarded a $188,307 Project Grant to the University of Pittsburgh under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2029. This award supports the development and testing of a guided, web-based behavioral treatment intervention that combines Acceptance and Commitment Therapy (ACT) for chronic pain with Mindfulness-Based Relapse Prevention (MBRP) for substance use disorders. The research...
- This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $742,500 Project Grant (R34) awarded on July 15, 2025, by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279). The three-year pilot award funds the development and testing of an innovative tobacco cessation intervention delivered by Peer Recovery Coaches (PRCs) in recovery from both opioid use disorder (OUD) and tobacco use disorder (TUD). The primary deliverables...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $431,750 to Rutgers, The State University of New Jersey to conduct research on informing national overdose prevention and treatment strategies for high-risk adolescents. The key objectives of this 2-year project are to: 1) estimate the prevalence of adolescent nonfatal drug overdose and identify high-risk demographic and clinical subgroups,...
- Federal Cooperative Agreement Summary New York University School of Medicine received a $1.75M Cooperative Agreement award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 15, 2025, with completion targeted for June 30, 2027. The award funds a stepped-wedge randomized controlled trial (RCT) designed to evaluate the effectiveness of a technical assistance (TA) intervention for preventing overdoses among residents of...